TRANSCATHETER AORTIC VALVE REPLACEMENT IN END STAGE LIVER DISEASE

Jose David, Tafur Soto, Theodora Valovska,Laurie Ventura, Kristen Thornton,Michael Bates,Patrick E. Parrino,Tyrone J. Collins

Journal of the American College of Cardiology（2017）

引用 0|浏览8

暂无评分

摘要

Background: Transcatheter aortic valve replacement (TAVR) has emerged as a therapeutic option to treat severe aortic stenosis in high-risk patients. Patients with cirrhosis and end-stage liver disease show high operative morbidity and mortality with cardiac surgery. The Society of Thoracic Surgeons

查看译文

关键词

liver

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要